Fairhaven Capital Partners
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Late Stage Venture
Geographical Focus
United States
Industries Focus
- Technology
- Automotive
- Software
- EdTech
- FinTech
- Health Care
- SaaS
- Artificial Intelligence
- Construction
- Manufacturing
- Internet
- B2B
- Information Technology
- Biotechnology
- Electronics
- Cyber Security
- Analytics
- Security
- Marketplace
- Nanotechnology
- Health Diagnostics
- Advanced Materials
- Advertising
- Cannabis
- Mobile Apps
- Cloud Security
- Software Engineering
- Wholesale
- Market Research
- Battery
- Network Security
- Data Visualization
- Motion Capture
Investor Details Founded: 2001
Fairhaven Capital Partners is a venture capital firm based in Cambridge, Massachusetts, specializing in early-stage investments in technology companies exhibiting rapid growth potential. The firm focuses on sectors such as FinTech, Internet, Marketplace, Advanced Materials, Battery, Electronics, Manufacturing, Cyber Security, Network Security, Software, Artificial Intelligence, Construction, Data Visualization, Information Technology, EdTech, Mobile Apps, Software Engineering, B2B, Cannabis, SaaS, Wholesale, Biotechnology, Health Care, Health Diagnostics, Automotive, Nanotechnology, Cloud Security, Security, Advertising, Analytics, Market Research, and Motion Capture. Their investment approach is characterized by a deep understanding of market dynamics and technology-based business models, enabling them to identify and support companies that can become market leaders. The team comprises experienced investors, data scientists, and computer scientists, fostering an integrated investment approach that leverages their diverse expertise. This collaborative environment enhances their ability to provide strategic guidance and resources to portfolio companies, facilitating their growth and success. Fairhaven Capital Partners has a track record of successful investments, including notable exits such as PathAI, Celtra, and Cylance. Their commitment to thorough analysis of market cycles, technologies, and industry trends informs their investment decisions, ensuring alignment with companies that have the potential to define markets and achieve significant growth. The firm's dedication to supporting high-potential startups is evident in their active involvement and hands-on approach, aiming to create value and drive innovation within their portfolio companies.
Requirements
- High growth potential
- Technology-based business models
- Early-stage companies
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- PathAI
- Celtra
- Cylance
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$24.95
-
$29.95
-
$14.95
-
$9.95
-
$19.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of Fairhaven Capital Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim